Picture of SpringWorks Therapeutics logo

SWTX — SpringWorks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapNeutral

Merck KGaA says the agreed bid for SpringWorks is final

April 28 (Reuters) - Merck KGaA's CEO said on Monday that the German group's  takeover price for U.S. biotech firm SpringWorks SWTX.O was firmly agreed and "final", when asked about the potential of any rival bidders for the takeover target.

 (Reporting by Ludwig Burger, editing by Rachel More)

 ((ludwig.burger@thomsonreuters.com;))

Recent news on SpringWorks Therapeutics

See all news